{
  "docId": "019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "docSlug": "6f650cb16e144ff2cbcc39c10e5d03e1",
  "documentTitle": "23andMe | Investor Presentation Deck | 39 slides",
  "authorId": "23andme",
  "authorName": "23andMe",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 23,
  "pageCount": 39,
  "prevPage": 22,
  "nextPage": 24,
  "slideType": "why_now",
  "function": "frame_problem",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "Includes survival curves, immunohistochemistry images, genetic association data, and clinical trial data for atopic dermatitis.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-8cfe-74f8-8267-71bfaaa75a6b/23",
  "deckHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b",
  "deckJsonHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b.json",
  "deckAnchorHref": "/decks/019de076-8cfe-74f8-8267-71bfaaa75a6b#slide-23",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.43,
        "x": 0.51,
        "y": 0.25
      },
      "kind": "callout",
      "text": "Potential activity in >60% of current patients not deriving efficacy from PD-(L)1 inhibitors",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1e81bd6-1644-4ef8-b166-645667601033",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.38,
        "x": 0.08,
        "y": 0.58
      },
      "kind": "chart",
      "text": "Genetic association of CD200R1, CD200, and DOK2 with various conditions",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bde0990a-9600-4501-83ff-a6a419cfa2a0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.28,
        "w": 0.43,
        "x": 0.51,
        "y": 0.62
      },
      "kind": "chart",
      "text": "Mean EASI Percent Change from Baseline by Treatment in Atopic Dermatitis",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1cac8c3d-fcc9-46e2-8255-9e2df1085908",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.22,
        "w": 0.36,
        "x": 0.09,
        "y": 0.23
      },
      "kind": "chart",
      "text": "Survival curves comparing targeted therapy vs standard therapy",
      "attrs": null,
      "subkind": "line",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "be4f85db-92e9-477b-b50f-c3b713ee6bf3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.43,
        "x": 0.51,
        "y": 0.34
      },
      "kind": "image",
      "text": "CD200 and CD200R1 immunohistochemistry images",
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "692a8d7e-fe9f-4360-a27c-51f59467b35d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.78,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "Lilly’s Ucenprubart: Clinical POC for CD200/R1 agonism in immune disease",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aeba9070-c22d-41bf-87cb-43e17ea61118",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.45,
        "x": 0.08,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "PMIDs: 12960329, 23602662, 22264927, 19786546, 15557172, 22491458, 15220441, 34326171, 18081533, 24388216, 11099416",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "207cc644-7646-4100-a167-324abfa1710b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.42,
        "x": 0.29,
        "y": 0.12
      },
      "kind": "title",
      "text": "Addressing Critical Unmet Need in Solid Tumors",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e0a2e8bd-0b30-4b02-b588-d0d4d106fb0f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.36,
        "x": 0.32,
        "y": 0.05
      },
      "kind": "title",
      "text": "'610 Development Rationale",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "15ef2ce2-0e94-4262-9768-10b01d264723",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Chart Selection Guide",
      "slug": "chart-selection-guide",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "2c178ce8-03c5-48f2-b2d8-ef1c51ce2a05",
      "evidence": "chart/line: Mean EASI Percent Change from Baseline by Treatment in Atopic Dermatitis",
      "confidence": 0.7
    },
    {
      "name": "Problem Statement Canvas",
      "slug": "problem-statement-canvas",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "6c8464ad-6f49-41f6-aa02-fea0f79994ba",
      "evidence": "paragraph/paragraph: Potential activity in >60% of current patients not deriving efficacy from PD-(L)1 inhibitors",
      "confidence": 0.6
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 9,
      "beatId": "93eec936-fceb-4bb2-ab9b-6265df978407",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution (Provide relief)",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "Slides 9-39 present 23andMe's solution, including their therapeutic pipeline and approach",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 26,
      "from": 23,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "222f1e4a-2305-4ee1-bc08-b05e43ea38f6",
      "evidence": "Slides 23-26 emphasize the importance of addressing unmet medical need in oncology",
      "position": 1,
      "objective": "Highlight the cost of inaction in addressing unmet medical need",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}